InvestorsHub Logo
Followers 144
Posts 27607
Boards Moderated 3
Alias Born 02/07/2004

Re: Spideyboy post# 2477

Tuesday, 04/25/2023 8:11:46 AM

Tuesday, April 25, 2023 8:11:46 AM

Post# of 2833
BioLineRx regains Nasdaq compliance

Apr. 25, 2023 7:36 AM ETBioLineRx Ltd. (BLRX)

By: Manshi Mamtora, CFA
Pre-commercial-stage biopharmaceutical company focused on oncology, BioLineRx (NASDAQ:BLRX) received formal notice from Nasdaq that the company has regained compliance with the minimum bid price requirement.

The company was notified on November 2, 2022, that its ADSs had failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.

From April 10, 2023 through April 21, 2023, a period of 10 consecutive trading days, the closing bid price of the company's ADSs was greater than $1.00 per share.

I wonder what the market reaction is to be the coming days!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News